Idexx Laboratories (IDXX) Free Cash Flow Growth (3y) (2012 - 2026)
Powered by 
Analysis
Idexx Laboratories (IDXX) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 23.11% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 216.31% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 134.18% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -17.62% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -139.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.11% |
| Mar 31, 2026 | 17.50% |
| Dec 31, 2025 | 37.99% |
| Sep 30, 2025 | 34.87% |
| Jun 30, 2025 | 61.85% |
| Mar 31, 2025 | 35.89% |
| Dec 31, 2024 | 9.32% |
| Sep 30, 2024 | 10.53% |
| Jun 30, 2024 | 0.57% |
| Mar 31, 2024 | 17.31% |
| Dec 31, 2023 | 2.00% |
| Sep 30, 2023 | 11.08% |
| Jun 30, 2023 | -1.99% |
| Mar 31, 2023 | 106.72% |
| Dec 31, 2022 | 4.29% |
| Sep 30, 2022 | 16.71% |
| Jun 30, 2022 | -29.79% |
| Mar 31, 2022 | 187.03% |
| Dec 31, 2021 | 20.22% |
| Sep 30, 2021 | 21.41% |